scholarly article | Q13442814 |
P50 | author | Lindsey A. Criswell | Q67485118 |
P2093 | author name string | Hisanori Umehara | |
Yan Zhao | |||
Wen Zhang | |||
Yi Dong | |||
Susumu Sugai | |||
Mengtao Li | |||
Caroline H Shiboski | |||
John S Greenspan | |||
Frederick B Vivino | |||
Alan N Baer | |||
Stephen C Shiboski | |||
Troy E Daniels | |||
Bruce W Kirkham | |||
Pekka Helin | |||
Kenneth E Sack | |||
Cristina F Vollenweider | |||
Arundathi S Malladi | |||
Ratukondla Banushree | |||
P2860 | cites work | Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients | Q33380356 |
An early view of the international Sjögren's syndrome registry. | Q33642772 | ||
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. | Q34473582 | ||
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants | Q35082455 | ||
Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors | Q35637298 | ||
A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry | Q36283986 | ||
Increased Risk of Lymphoma in Sicca Syndrome | Q39632164 | ||
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome | Q40650085 | ||
Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome | Q46463584 | ||
Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). | Q46821765 | ||
Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. | Q51990664 | ||
The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. | Q54074342 | ||
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. | Q55033876 | ||
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. | Q55047291 | ||
Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors | Q56907577 | ||
Clinical criteria for the diagnosis of salivary gland hypofunction | Q68204847 | ||
Diagnostic tests in the Sicca syndrome | Q70112003 | ||
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME | Q76799561 | ||
Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort | Q82361734 | ||
P433 | issue | 6 | |
P921 | main subject | Sjögren's syndrome | Q335555 |
P304 | page(s) | 911-918 | |
P577 | publication date | 2012-01-11 | |
P1433 | published in | Arthritis Care and Research | Q15754720 |
P1476 | title | Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry | |
P478 | volume | 64 |
Q37689805 | A Potential of sFasL in Preventing Gland Injury in Sjogren's Syndrome |
Q36219673 | A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome. |
Q87641867 | A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience |
Q93014132 | Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome |
Q34260251 | American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort |
Q36477926 | Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome. |
Q64071033 | Association between Periodontal Disease and Subsequent Sjögren's Syndrome: A Nationwide Population-Based Cohort Study |
Q38747090 | Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases. |
Q33822678 | B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences |
Q33721046 | Clinical and laboratorial profile and histological features on minor salivary glands from patients under investigation for Sjögren's syndrome |
Q38133017 | Clinical aspects of autoimmune rheumatic diseases |
Q40562190 | Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study |
Q96136718 | Complement genes contribute sex-biased vulnerability in diverse disorders |
Q38910066 | Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features. |
Q38119877 | Cutaneous vasculitis: a rheumatologist perspective |
Q36658257 | Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction |
Q49355856 | Fibrillary Glomerulonephritis in Primary Sjogren's Syndrome: A Rare Cause of Renal Failure |
Q42057367 | Health-related quality of life and depression among participants in the Sjögren's International Collaborative Clinical Alliance registry |
Q53837951 | Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016. |
Q38401667 | Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort |
Q50632451 | Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. |
Q39232871 | Innate immunity in Sjögren's syndrome. |
Q40225870 | Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands. |
Q39173291 | Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms. |
Q59794256 | Isolated end-stage renal disease in Sjögren's syndrome due to immune complex mediated glomerulonephritis |
Q64092321 | Laryngological manifestations of Sjögren's syndrome |
Q47676645 | Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients |
Q91687973 | MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1 |
Q36001863 | Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome |
Q47739264 | Myd88 is required for disease development in a primary Sjögren's syndrome mouse model. |
Q40230222 | Natural history and Predictors of Progression to Sjögren's Syndrome Among Participants of the SICCA registry. |
Q90092076 | Prevalence of Novel Candidate Sjögren Syndrome Autoantibodies in the Penn Sjögren's International Collaborative Clinical Alliance Cohort |
Q34249846 | Primary Biliary Cirrhosis and Primary Sjögren's Syndrome: Insights for the Stomatologist |
Q36152109 | Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients |
Q39562627 | Primary Sjögren's syndrome is associated with significant cognitive dysfunction. |
Q49039960 | RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis |
Q38633492 | Renal involvement in primary Sjögren syndrome |
Q47199815 | Role of inflammasomes in inflammatory autoimmune rheumatic diseases |
Q37041516 | Single-cell analysis of glandular T cell receptors in Sjögren's syndrome. |
Q65001289 | Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset. |
Q39019614 | Sjögren Syndrome and Other Causes of Sicca in Older Adults |
Q87353703 | Sjögren syndrome |
Q64921582 | Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis. |
Q57337387 | Sjögren’s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin |
Q34464370 | Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome |
Q47758400 | Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2b/J mouse model. |
Q38913854 | The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis |
Q39033400 | The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome. |
Q38110936 | The future of B cell-targeted therapies in Sjögren's syndrome |
Q38622370 | The management of autoimmunity in patients with cholestatic liver diseases |
Q38186111 | The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms. |
Q90003803 | Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults |
Q50667547 | Voice, speech, and laryngeal features of primary Sjögren's syndrome. |
Q87328501 | [Sjögren's syndrome] |
Search more.